Bone marker assessment as a guide to chronic use of aminobisphosphonates in multiple myeloma.

8140 Background: Aminobisphosphonates (aBP) are standard of care for myeloma related bone disease and are recommended every 3-4 weeks. Our previous data suggests altered bone remodeling in osteonec...